|
FREE Newsletter Timely Market Commentary Daily Stock Picks News Analysis |
|
CRWESelect.com tracks stocks daily and is pleased to offer its stock watch highlights. Investors can register to receive FREE Stock Watch Highlights by giving us your e-mail address in the box identified as Free Alerts located in the right column.
In The News:
Retailers report sales gains for August
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Healthmed Services Ltd. (HEME.OB) formed in 2000 when technology was on the rise. The focus of the company has been to develop products to better efforts of the healthcare industry through the use of technology. The company works on a revolutionary product that will forever change the way the healthcare industry communicates within itself.
**HealthMed Services to Acquire Neural Communicator
Today HEME, an innovative software development company, is pleased to announce that it has entered final negotiations to acquire all rights, title and interest to Neural Communicator software and hardware.
Neural Communicator has developed brain/computer interface devices and software designed to enable people with extreme disabilities to communicate. The device detects eye movement, jaw contractions and ALPHA and BETA brain waves allowing hands free input.
Neural Communicator is intended for people disabled in such a way that they cannot communicate by speech or by using their body. Biofeedback is used for computer input and controlling the application features.
The developers of the software and hardware will continue to work with HealthMed on an outsourcing basis in developing further applications for the Neural Communicator.
For more information about this company please visit http://www.healthmedltd.com
Medtronic, Inc. (NYSE:MDT) is the global leader in medical technology - alleviating pain, restoring health, and extending life for millions of people around the world.
**Medtronic Receives Health Canada Approval for the Newest Radiofrequency Ablation Tools for Atrial Fibrillation
The company MDT recently announced it received Health Canada approval for the Medtronic Ablation Frontiers Cardiac Ablation System, a novel radiofrequency (RF) ablation technology for the treatment of atrial fibrillation (AF).
AF is the most common heart arrhythmia that affects more than 250,000 Canadians and seven million people worldwide.
The Medtronic Ablation Frontiers Cardiac Ablation System tools now approved for use in Canada include the GENius(TM) Multi-Channel Radiofrequency Generator and the Pulmonary Vein Ablation Catheter (PVAC)(TM), a single anatomically shaped mapping and ablation catheter designed to efficiently isolate the pulmonary veins to treat AF.
The GENius generator and PVAC, with the addition of the Multi-Array Septal Catheter (MASC)(TM) and Multi-Array Ablation Catheter (MAAC)(TM), are available in Europe and are under investigational use in the United States.
Medtronic will provide periodic clinical updates on the safety and effectiveness of the PVAC catheter as a condition of Health Canada’s approval.
For more information about this company please visit http://www.medtronic.com
Varian Medical Systems, Inc. (NYSE:VAR) is the world’s leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy.
The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices.
Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection.
Varian Medical Systems employs approximately 5,200 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world.
**Varian Medical Systems Establishes Radiotherapy Training Center in Mumbai, India
The company VAR recently has established its first education center in India to train medical physicists and technologists working on the company’s advanced cancer treatment systems.
The center in Mumbai, equipped with 16 planning system workstations and the VERT training system for radiotherapy treatment simulations, will enable the country’s growing number of radiotherapists and medical physicists to train without having to travel overseas.
The official opening, which was attended by Kanta Chokkra, president of the Association of Medical Physicists of India, was carried out by Kolleen Kennedy, Varian’s VP Customer Support Services.
For more information about this company please visit http://www.varian.com
CRWESelect, a stock highlight publication is pleased to alert investors of stocks on the move.
Sign Up for our Free Stock Newsletter at http://www.crweselect.com/signup
PLEASE BE SURE TO VISIT CRWESELECT.NING.COM
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received five thousand dollars in cash from a third party (Media Elite Consultants LLC) for (1) day of advertising for Healthmed Services Ltd. (OTC BB: HEME.OB)
HEMEcrweselect0902
Healthmed Services Ltd. (HEME.OB)
SUNNYVALE, CA–(CRWENEWSWIRE - 09/02/10) - HealthMed Services Ltd., an innovative software development company, is pleased to announce that it has entered final negotiations to acquire all rights, title and interest to Neural Communicator software and hardware.
Neural Communicator has developed brain/computer interface devices and software designed to enable people with extreme disabilities to communicate. The device detects eye movement, jaw contractions and ALPHA and BETA brain waves allowing hands free input.
Neural Communicator is intended for people disabled in such a way that they cannot communicate by speech or by using their body. Biofeedback is used for computer input and controlling the application features.
The software is based on plug-in architecture allowing easy implementation of new features. There are five basic modules:
Speech module - text input for speech replacement; GSM module - send and receive SMS; MSN module; Windows Live Messenger chat Book Reader - reading books by speech synthesis; and Web Browsing - special plug-ins for Bing Maps and Facebook.
The developers of the software and hardware will continue to work with HealthMed on an outsourcing basis in developing further applications for the Neural Communicator.
President/CFO John Popovic commented, “We are extremely keen on completing the acquisition of Neural Communicator. The product will bring easy communication capability to those currently unable to communicate as well as expanding the communication ability of others with disabilities restricting their communication capacity. Acquiring this leading edge technology expands HealthMed’s product lineup and will position us strongly in the marketplace.”
For more information about this company please visit http://www.healthmedltd.com
CRWESelect, a stock highlight publication is pleased to alert investors of stocks on the move.
Sign Up for our Free Stock Newsletter at http://www.crweselect.com/signup
PLEASE BE SURE TO VISIT CRWESELECT.NING.COM
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received five thousand dollars in cash from a third party (Media Elite Consultants LLC) for (1) day of advertising for Healthmed Services Ltd. (OTC BB: HEME.OB)
HEMEcrweselect0902
HealthMed Services LTD, HEME.OB
Charting a New Course in Saving Lives
HealthMed Services LTD (HEME.OB) is a company for the record.
HealthMed, an innovative software development company, is pleased to announced today that it has entered final negotiations to acquire all rights, title and interest to Neural Communicator software and hardware.
Neural Communicator has developed brain/computer interface devices and software designed to enable people with extreme disabilities to communicate. The device detects eye movement, jaw contractions and ALPHA and BETA brain waves allowing hands free input.
Neural Communicator is intended for people disabled in such a way that they cannot communicate by speech or by using their body. Biofeedback is used for computer input and controlling the application features.
The software is based on plug-in architecture allowing easy implementation of new features. There are five basic modules: Speech module - text input for speech replacement; GSM module - send and receive SMS; MSN module; Windows Live Messenger chat Book Reader - reading books by speech synthesis; and Web Browsing - special plug-ins for Bing Maps and Facebook.
The developers of the software and hardware will continue to work with HealthMed on an outsourcing basis in developing further applications for the Neural Communicator.
HealthMed, a development stage company is developing a revolutionary new remote software product called Virtual Vantage that will simplify record- keeping and mobilize healthcare professionals. This software will increase efficiency of staff by allowing them to interact with their stationary PC from anywhere within the facility. Therefore, electronic charting and updating patient records will alleviate the workload of healthcare professionals.
HeatlthMed also intends to provide individuals, companies, and health-provider organizations with telephone and Web-based access to medical advice, information, and products and services in the United States and internationally.
More Information On HealthMed Can Be Found At: http://www.healthmedltd.com
**********************************************************************
Medicis Pharmaceutical, MRX
It’s the scourge of teenagers everywhere. But for Medicis Pharmaceutical (NYSE:MRX), acne is no curse. It’s a multibillion-dollar-a-year market opportunity.
Medicis develops and markets various drugs, gels and creams to treat a range of dermatological and aesthetic conditions. Its focus is helping people look healthy and youthful.
The 22-year-old company also has wrinkle-fighting products for older adults, and is working on U.S. regulatory approval for a device that uses ultrasound to attack fat cells beneath the skin.
Making wrinkles go away is a growth market, with demographics giving a boost. Baby boomers are already shelling out money to look young. And their children, the so-called echo boomers, are creeping into their 30s now, heading toward their first laugh lines.
Acne Creams
But those prescription acne creams and treatments are still the main driver at Medicis, accounting for almost 70% of last year’s $572 million in sales. Medicis thinks Americans alone will spend $5.8 billion this year to treat acne and other dermatological conditions.
Medicis Pharmaceutical Corporation, a specialty pharmaceutical company, engages in the development and marketing of products for the treatment of dermatological and aesthetic conditions in the United States, Canada, and Europe. The company’s products address various conditions or aesthetic improvements, including facial wrinkles, glabellar lines, acne, fungal infections, rosacea, hyperpigmentation, photoaging, psoriasis, seborrheic dermatitis, and cosmesis.
For More Information On Medicis Visit Their Website: http://www.medicis.com
**********************************************************************
Managed care company HealthSpring Inc (NYSE:HS) said it agreed to pay $545 million to acquire a privately held operator of Medicare plans to gain access to customers who are not bound by enrollment restrictions, driving its shares up to a 52-week high.
The acquisition of Bravo Health Inc also comes with the Baltimore-based company’s strong presence in the Philadelphia and Texas markets.
“Approximately 50 percent of the Bravo members are dual eligible beneficiaries who are not confined to strict annual enrollment periods that non-dual eligible Medicare members face and therefore can enroll with plans at any point throughout the year,” HealthSpring Chief Executive Herb Fritch said.
The recently passed U.S. healthcare reform bill will restrict, from the next enrollment year, the period and options for Medicare beneficiaries to change their plans, once they have signed on for the year.
The deal will hurt HealthSpring’s 2010 earnings by about 20 cents a share, but add between 45-55 cents to its 2011 earnings, the company said in a statement. The transaction will be financed through cash and debt under an amended revolving credit facility and new term loans.
HealthSpring, Inc., through its subsidiaries, operates as a managed care organization in the United States. It focuses primarily on Medicare, the federal government sponsored health insurance program for the U. S. citizens aged 65 and older, qualifying disabled persons, and persons suffering from end stage renal disease in the states of Alabama, Florida, Illinois, Mississippi, Tennessee, and Texas. The company also provides management services to healthcare plans and physician partnerships
Visit HealthSpring’s website to find out more: http://www.myhealthspring.com
********************************************************************
The Views and Opinions Expressed by the author are his or her opinions only and do not necessarily reflect those of this Web-Site or its agents, affiliates, officers, directors, staff, or contractors. The author at the time of this article did not own any shares or receive any consideration financial or otherwise from any company or person mentioned or referred to in the article.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWENewswire.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWENewswire.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwenewswire.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.(CRWE.OB) has received five thousand dollars in cash from a third party (Media Elite Consultants LLC) for (1) day of advertising for Healthmed Services Ltd. (OTC BB: HEME.OB)
Healthmed Services Ltd. (HEME.OB) formed in 2000 when technology was on the rise. The focus of the company has been to develop products to better efforts of the healthcare industry through the use of technology. The company works on a revolutionary product that will forever change the way the healthcare industry communicates within itself.
**HealthMed Services to Acquire Neural Communicator
Today HEME, an innovative software development company, is pleased to announce that it has entered final negotiations to acquire all rights, title and interest to Neural Communicator software and hardware.
Neural Communicator has developed brain/computer interface devices and software designed to enable people with extreme disabilities to communicate. The device detects eye movement, jaw contractions and ALPHA and BETA brain waves allowing hands free input.
Neural Communicator is intended for people disabled in such a way that they cannot communicate by speech or by using their body. Biofeedback is used for computer input and controlling the application features.
The developers of the software and hardware will continue to work with HealthMed on an outsourcing basis in developing further applications for the Neural Communicator.
For more information about this company please visit http://www.healthmedltd.com
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is a biotechnology company engaged in the research and
development of therapeutics and diagnostics, with a particular emphasis on products targeted for the unmet needs of the aging population.
The Company’s new drug for benign prostatic hyperplasia (BPH) is in Phase 3 development.
Nymox has a number of drugs in development for other indications such as E. coli infection, Alzheimer’s disease, oncology, and infectious disease.
The Company offers NicAlertTM and TobacAlertTM tests for measuring tobacco product exposure, and AlzheimAlert TM, a test to aid in the diagnosis of Alzheimer’s disease.
** Nymox Reported Second Quarter 2010 Financial Results
The Company NYMX product sales amounted to $104,550 for the quarter and $351,411 for the six months ending June 30, 2010, compared to $80,341 and $176,567 for the same periods in 2009.
Sales of NicAlert/TobacAlert to new clients explains the increase in sales for the quarter and the six months ended June 30, 2010 compared to the same periods in 2009.
The weighted average number of common shares outstanding for the six months ended June 30, 2010 was 31,627,450 compared to 30,412,501 for the same period in 2009.
For more information about this company please visit http://www.nymox.com
Omega Healthcare Investors Inc. (NYSE:OHI) is a real estate investment trust investing in and providing financing to the long-term care industry.
**Omega Reported Second Quarter 2010 Financial Results
For the three-month period ended June 30, 2010, OHI recently reported net income of $15.5 million and net income available to common stockholders of $13.2 million, or $0.14 per diluted common share on operating revenues of $58.8 million.
This compares to net income of $19.8 million and net income available to common stockholders of $17.6 million, or $0.21 per diluted common share on operating revenues of $49.2 million, for the same period in 2009.
For the six-month period ended June 30, 2010, OHI recently reported net income of $36.5 million, net income available to common stockholders of $31.9 million, or $0.35 per diluted common share on operating revenues of $117.5 million.
This compares to net income of $44.7 million, net income available to common stockholders of $40.2 million, or $0.49 per diluted common share on operating revenues of $98.3 million, for the same period in 2009.
For more information about this company please visit http://www.omegahealthcare.com
CRWESelect, a stock highlight publication is pleased to alert investors of stocks on the move.
Sign Up for our Free Stock Newsletter at http://www.crweselect.com/signup
PLEASE BE SURE TO VISIT CRWESELECT.NING.COM
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received five thousand dollars in cash from a third party (Media Elite Consultants LLC) for (1) day of advertising for Healthmed Services Ltd. (OTC BB: HEME.OB)
HEMEcrweselect0902
Healthmed Services Ltd. (HEME.OB) formed in 2000 when technology was on the rise. The focus of the company has been to develop products to better efforts of the healthcare industry through the use of technology. The company works on a revolutionary product that will forever change the way the healthcare industry communicates within itself.
The company HEME was incorporated in the state Nevada on September 14, 2000.
Since inception, the objective of the company has been to utilize communications technology to provide individuals, companies and healthprovider organizations optimal service to increase their productivity and better the healthcare environment as a whole.
HEME has created remote desktop client software which allows the iPad information to communicate directly with a desktop pc or server.
This will allow records to be electronically created and stored, rather than manual printing and scanning.
This will reduce required manpower for pushing paper.
This will allow for more accurate record keeping, thus decreasing lawsuits in a litigious society.
Most importantly, it will also free up more time for healthcare professionals thus allowing more time to be spent with clients or family.
Regarding the healthcare industry, President Obama has pledged 630 billion dollars over the next 10 years to the industry.
The US American Recovery and Reinvestment Act of 2009 has already awarded 70 billion dollars through the US Department of Health and Human Services to the healthcare industry. According to Juniper Research, spending on mobile hardware, software and services across the global healthcare sector is set to rise to $2.7 billion in 2010.
Today, research firms point to positive growth in hardware and software spending, which will contribute to a tech recovery in 2010. However, despite the recession, more than 50% of companies are still increasing their IT budget annually.
According to Forrester’s research for the first quarter, U.S. spending on information and communications technology products and services will reach 741 billion dollars in 2010.
Andrew Bartels, vice president and principal analyst at Forrester Research, stated, “I now expect the U.S. IT market to grow by 8.4%, a bit higher than my earlier forecast, because of better-than-expected performance in communications equipment.”
Stay Tuned!
For more information about this company please visit http://www.healthmedltd.com
CRWESelect, a stock highlight publication is pleased to alert investors of stocks on the move.
Sign Up for our Free Stock Newsletter at http://www.crweselect.com/signup
PLEASE BE SURE TO VISIT CRWESELECT.NING.COM
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received five thousand dollars in cash from a third party (Media Elite Consultants LLC) for (1) day of advertising for Healthmed Services Ltd. (OTC BB: HEME.OB)
HEMEcrweselect0902
